High glucose alters cardiomyocyte contacts and inhibits myofibrillar formation

The Journal of Clinical Endocrinology and Metabolism
Daniela DyntarMarc Y Donath

Abstract

The frequency of diabetes-related heart failure along with the prevalence of diabetes is increasing. Diabetic cardiomyopathy is considered to be a distinct disease in the absence of discernible coronary artery and other defined heart disease. Previously we have shown that glucose and palmitic acid induce degeneration of myofibrils and modulate apoptosis in cultivated cardiomyocytes. Here we studied the mechanisms of diabetic cardiomyopathy in more detail. Streptozotocin-induced diabetes led to a significant increase in cardiac cell apoptosis. Furthermore, cardiomyocyte contacts were reduced. In vitro, prolonged exposure of cultured adult cardiomyocytes to high glucose concentrations drastically reduced myofibrillar formation. In particular, sarcomeric myosin heavy chains and cardiac alpha-actin were reduced, whereas the nonsarcomeric smooth muscle alpha-actin remained unaffected. The deleterious effects of glucose on myofibril formation were prevented by antioxidative regimens. Thus, a diabetic milieu leads to multiple structural alterations of the heart including apoptosis, loss of intercellular contacts, and malformation of contractile structures.

Citations

Oct 28, 2011·American Journal of Physiology. Cell Physiology·Rita M MaaloufHanna E Abboud
Mar 5, 2009·American Journal of Physiology. Endocrinology and Metabolism·Junqin ChenAnath Shalev
Dec 7, 2011·Experimental Diabetes Research·Jiancheng XuLu Cai
Apr 9, 2008·Journal of Clinical Biochemistry and Nutrition·Zhenhua LiZhiming Ge
Jun 16, 2012·International Journal of Medical Sciences·Xiaohong XuTongfeng Zhao
Apr 30, 2014·Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire·Dongmei SuXu Ma
Jul 31, 2014·The Journal of Endocrinology·Yoswaris SemamingNipon Chattipakorn
Sep 11, 2014·Cell Calcium·Laetitia PereiraAna María Gómez
Feb 25, 2011·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Tingting WuZhiming Ge
Nov 10, 2010·European Journal of Haematology·Sirinart KumfuNipon Chattipakorn
Sep 10, 2015·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Qianqian GaoXu Ma
Sep 25, 2014·The Anatomical Record : Advances in Integrative Anatomy and Evolutionary Biology·I G DanilovaA P Sarapultsev
Aug 16, 2016·American Journal of Physiology. Heart and Circulatory Physiology·Gábor KoncsosPéter Ferdinandy
Aug 17, 2014·American Journal of Physiology. Heart and Circulatory Physiology·Magali BalteauChristophe Beauloye
Aug 2, 2018·Médecine sciences : M/S·Alexandre LugatXavier Prieur
Sep 22, 2020·World Journal of Stem Cells·Andy Chun-Hang ChenYin Lau Lee
Apr 15, 2009·Clinical Science·Omar AsgharRayaz A Malik
Apr 17, 2021·Journal of Diabetes Research·Xiu WangWeina Hu
Aug 14, 2021·Journal of Muscle Research and Cell Motility·Hamida AboalgasmAsfree Gwanyanya
Sep 4, 2021·Tissue Engineering. Part B, Reviews·Tori SalemJared M Churko
Nov 16, 2020·Archives of Cardiovascular Diseases·Sylvain BattaultLuc Bertrand
Oct 18, 2007·Current Opinion in Endocrinology, Diabetes, and Obesity

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis